Severe COVID-19 infection in a patient with a blastic transformation of a chronic myeloid leukemia and severe treatment-induced immunosuppression: a case reportCase Report Published on 2020-11-112022-10-28 Journal: The Pan African Medical Journal [Category] COVID-19, MERS, [키워드] acute respiratory syndrome appear benefit cancer patient Cancer patients cancer treatment Care Case report Chemotherapy complications coronavirus COVID-19 COVID-19 infection COVID-19 pandemic develop Diagnosis globe hematological hospital Immunocompromised infecting Leukaemia leukemia Measures mild symptoms outcome pandemic Patient Prophylactic risk SARS-CoV-2 Spread while with COVID-19 [DOI] 10.11604/pamj.supp.2020.37.1.25501 PMC 바로가기 [Article Type] Case Report
Perspectives of cancer patients and their health during the COVID-19 pandemicResearch Article Published on 2020-10-302022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] analyses Cancer cancer patient cancer treatment Care caused Chemotherapy conducted coronavirus COVID-19 COVID-19 pandemic cross-sectional distress Effect Effects Efficacy Facebook Fisher’s exact tests greater group Health immunosuppressive implication individual Infection information metastatic disease Modification negatively affected participant Patient promoted provided public health receiving recruited reported Result risk of infection SARS-COV-2 infection T-tests the SARS-CoV-2 The United States therapy Treatment [DOI] 10.1371/journal.pone.0241741 PMC 바로가기 [Article Type] Research Article
Managing a gastrointestinal oncology practice in Japan during the COVID-19 pandemic: single institutional experience in The Cancer Institute Hospital of Japanese Foundation for Cancer ResearchOriginal Article Published on 2020-10-212022-10-30 Journal: International journal of clinical oncology [Category] COVID-19, MERS, SARS, [키워드] cancer patient cancer treatment Care Chemotherapy Coronavirus disease 2019 COVID COVID-19 Efficacy foundation Gastrointestinal oncology global pandemic Health healthcare professionals implication Infection Japan Japanese managing medical resource morbidity and mortality oncologist oncology outlined pandemic Patient reduce risk of COVID-19 severe adverse events shown with COVID-19 World Health Organization [DOI] 10.1007/s10147-020-01806-7 PMC 바로가기 [Article Type] Original Article
Comprehensive review of implications of COVID‐19 on clinical outcomes of cancer patients and management of solid tumors during the pandemicReview Published on 2020-10-202022-10-31 Journal: Cancer Medicine [Category] COVID-19, MERS, SARS, [키워드] adverse event Cancer cancer patient Cancer patients cancer treatment change clinical feature Clinical outcome clinically Comprehensive COVID‐19 COVID‐19 infection COVID‐19 detrimental disease Effect event Fatality rate globe Health Immunocompromised implication increased risk Infection lung malignancy management mitigate morbidity and mortality Mortality oncology outcomes pandemic Patient patient population Prostate cancer Radiation recommendation recommendations review article risk shown solid tumor Spread surgical susceptible Therapies treat unique Vaccines [DOI] 10.1002/cam4.3534 PMC 바로가기 [Article Type] Review
Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy)Article Published on 2020-10-122022-10-31 Journal: Cancers [Category] COVID-19, [키워드] A significant reduction adverse outcome anticancer Cancer cancer patient Cancer patients cancer treatment Care characteristics of patient clinic clinical condition Containment measure containment measures continuum coronavirus disease COVID-19 COVID-19 pandemic death evaluated flu fraction hospital ICS Impact incidence of COVID-19 Infection Italy lockdown lombardy management no significant difference oncology outbreak Outpatient outpatient clinic pandemic Patient patients Pavia performed quarantine radiological reduction in released reported risk factor Safe SARS-CoV-2 simple syndrome systemic treatment therapeutic therapy Travel Treatment was performed worsening [DOI] 10.3390/cancers12102941 PMC 바로가기 [Article Type] Article
Ethical Considerations for Treating Cancer Patients During the SARS-CoV-2 Virus Crisis: To Treat or Not to Treat? A Literature Review and Perspective From a Cancer Center in Low-Middle Income CountryMedicine Published on 2020-10-072022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] addition Applying Cancer cancer care Cancer center cancer patient Cancer patients cancer treatment center complex consequence Consequences COVID-19 criteria Critically ill DNR Ethics guidelines Health healthcare Healthcare provider higher risk Hussein illness immune system include income Infection King literature non-infected pandemic Patient patients physician PROTECT Providing resource review routine care SARS-CoV-2 SARS-CoV-2 infected patients SARS-COV-2 infection SARS-CoV-2 patients SARS-CoV-2 treatment severe complications shifting the SARS-CoV-2 treating Vaccine [DOI] 10.3389/fmed.2020.561168 PMC 바로가기 [Article Type] Medicine
SARS‐CoV‐2 infections in cancer outpatients—Most infected patients are asymptomatic carriers without impact on chemotherapyOriginal Research Published on 2020-10-062022-10-31 Journal: Cancer Medicine [Category] COVID-19, MERS, SARS, [키워드] Algorithm Asymptomatic Asymptomatic carrier Cancer cancer patient cancer treatment Chemotherapy clinics Complication Course COVID‐19 COVID‐19 infection disease disease severity glucocorticoid immune system immunosuppressive infected patient Infection investigated malignant disease Mild symptom mild symptoms oncology patient pandemic Patient patients Pneumonia positive question reduce risk SARS‐CoV‐2 SARS‐CoV‐2 infection Seven Symptom symptomatic Symptoms tested the patient therapy [DOI] 10.1002/cam4.3435 PMC 바로가기 [Article Type] Original Research
COVID-19 and radiation oncology: the experience of a two-phase plan within a single institution in central ItalyResearch Published on 2020-09-292022-10-29 Journal: Radiation Oncology (London, England) [Category] Coronavirus, SARS, [키워드] Accelerator Cancer patients cancer treatment coronavirus COVID-19 COVID-19 emergency Follow-up Follow-up visit healthcare professionals hospital Italy Laboratory management measure Ministry of Health pandemic Patient performed Personal protective equipment Phase I positive COVID-19 protocol Radiation Radiation Oncology Radiotherapy recorded reducing Result risk SARS-CoV-2 Simulation Swab test Treatment [DOI] 10.1186/s13014-020-01670-9 PMC 바로가기 [Article Type] Research
Immune Checkpoints in Viral InfectionsReview Published on 2020-09-212022-10-28 Journal: Viruses [Category] COVID-19, [키워드] antiviral therapy applied Cancer cells cancer treatment chronic infection COVID-19 Evidence immune immune checkpoint Immune checkpoint blockade immune system Immunotherapy in viral increasingly infections mechanism mounted recent finding regulate suggested T-cell therapy viral infection viral infections virus virus-infected cells [DOI] 10.3390/v12091051 PMC 바로가기 [Article Type] Review
Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in MadridOncology Published on 2020-09-162022-10-31 Journal: Frontiers in Oncology [Category] COVID-19, [키워드] abnormality acute respiratory distress Admission affected Anti-viral treatment anticoagulation ARDS baseline cancer patient cancer treatment conditions coronavirus Corticosteroids cough COVID-19 COVID-19 illness D-dimer diagnosed with COVID-19 Diagnosis discharged elevated Fever fibrinogen first positive high mortality rate high variability hospital Hospitalization hospitalized patient Hydroxychloroquine Immunotherapy incidence inflammation marker Inflammatory invasive lab lung cancer lung cancer patient lung cancer patients lymphocyte measure Mortality Multiple multivariate multivariate model neutrophil no difference outcome pandemic Patient patients PCR Pneumonia PROTECT Protein receiving risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 PCR SARS-CoV-2 RT-PCR Shortness of breath Spain statistically significant symptoms onset syndrome targeted therapy Tertiary therapy Thoracic time Tocilizumab Treatment variable [DOI] 10.3389/fonc.2020.01777 PMC 바로가기 [Article Type] Oncology